Travmatologiya i ortopediya Rossii is a pivotal open access journal dedicated to the fields of trauma, orthopedics, and rehabilitation, published by the esteemed Vreden Russian Research Institute of Traumatology & Orthopedics. With an ISSN of 2311-2905, this journal serves as a vital resource for researchers, healthcare professionals, and students in the Russian Federation and beyond. Since its establishment, the journal has fostered a commitment to advancing knowledge in its scope areas, contributing significantly to medical practice and research. Although it currently holds a Q4 quartile ranking in multiple fields including Microbiology, Oncology, and Orthopedics, the journal’s impact in supporting innovative research and clinical advancements remains noteworthy. By providing a platform for open access articles since 2010, it ensures that crucial findings reach a wide audience, enhancing collaborative efforts within the global medical community. As the journal converges from 2021 to 2024, it aims to continuously improve its quality and visibility, making it an essential addition to any academic library.

The HSS Journal, published by SAGE Publications Inc, is a prominent scholarly journal dedicated to advancing knowledge in the fields of Orthopedics, Sports Medicine, and Surgery. With a robust ISSN of 1556-3316 and E-ISSN 1556-3324, this journal has been rigorously contributing to the medical community since its inception in 2006, with a convergence set to last through 2024. The journal boasts a commendable impact factor, positioning it in the Q2 category for both Orthopedics and Sports Medicine, as well as Surgery, highlighting its significance and credibility within these domains. The HSS Journal's Scopus rankings further underscore its scholarly impact, placing it in the 75th percentile for Surgery and 67th percentile for Orthopedics and Sports Medicine. Dedicated to providing high-quality, peer-reviewed articles, the journal serves as an essential resource for researchers, clinicians, and students eager to stay abreast of the latest advancements and best practices in surgical care and orthopedics.

MYCOSES is a renowned academic journal published by Wiley, specializing in the fields of Dermatology, Infectious Diseases, and general Medicine, with a commendable focus on mycological research and its clinical implications. Established in 1957, this journal has significantly contributed to advancing our understanding of fungal diseases, offering a platform for high-quality research that ranks among the top in its categories—achieving Q1 status in Dermatology and Q1 in Medicine (miscellaneous), while maintaining a strong Q2 ranking in Infectious Diseases. With an impressive Scopus ranking of #5 in Medicine - Dermatology, MYCOSES occupies a pivotal position in the dissemination of critical findings and innovative practices within the scientific community. Although it is not an open-access journal, MYCOSES continues to attract a wide array of researchers, professionals, and students seeking to enhance their knowledge and keep abreast of the latest developments in mycology. Overall, MYCOSES not only serves as an essential resource for academia but also plays a vital role in shaping future research directions and clinical approaches to fungal infections.

Journal of Pediatric Infection is a vital academic resource dedicated to the ever-evolving field of infectious diseases in pediatric populations. Published by AVES YAYINCILIK in Turkey, this journal features a rigorous peer-review process and has established itself as a platform for innovative research from around the globe. Although currently categorized in the Q4 quartile for both Infectious Diseases and Pediatrics, Perinatology and Child Health, the journal's potential for growth is substantial, attracting contributions that aim to shed light on the complexities of infectious diseases affecting children. With a converged publication history from 2009 to 2024, the journal emphasizes the importance of advancing knowledge in pediatric health through systematic reviews, original research, and case studies. Its open access policy encourages unrestricted sharing of vital research findings, making it an essential read for researchers, clinicians, and students dedicated to improving pediatric healthcare outcomes.

BURNS, published by Elsevier Science Ltd, is a leading academic journal focused on the multidisciplinary study of burn injuries and their management. With a strong reputation in the field, it holds impressive rankings, including Q1 in Emergency Medicine and Q2 in Critical Care and Intensive Care Medicine, reflecting its significant impact on clinical practices and research advancements. The journal, with an ISSN of 0305-4179 and E-ISSN 1879-1409, has served the academic community since 1974 and continues to provide a platform for innovative research until 2024 and beyond. While it is not currently an open-access publication, BURNS remains an essential resource for researchers, practitioners, and students seeking to enhance their understanding of burn care and associated medical fields. With a focus on critical insights, the journal plays a vital role in advancing knowledge and improving patient outcomes in burn treatment and rehabilitation.

Therapeutic Advances in Infectious Disease is a distinguished journal published by SAGE Publications Ltd, dedicated to advancing knowledge in the vital field of infectious diseases and pharmacology. With an impactful Open Access model since 2019, the journal facilitates unrestricted access to a wealth of high-quality research, enabling researchers, clinicians, and educators to stay at the forefront of infectious disease management and treatment. As a recognition of its contribution to the scientific community, the journal holds a prestigious Q1 quartile ranking in both Infectious Diseases and Medical Pharmacology as of 2023, underscoring its influence and relevance in these domains. The journal is positioned favorably within the Scopus rankings, with an impressive standing in the diverse categories of Medicine, emphasizing its commitment to disseminating innovative research. Through a rigorous peer-review process and a broad scope that covers therapeutic advancements, Therapeutic Advances in Infectious Disease serves as an essential resource for anyone involved in combating infectious diseases, offering insights that drive clinical applications and enhance patient care.

Bone & Joint Open, an esteemed journal published by the British Editorial Society of Bone & Joint Surgery, represents a significant advancement in the dissemination of research in the field of orthopedics and sports medicine. With an E-ISSN of 2633-1462, this Open Access journal has been providing unrestricted access to high-quality research since its inception in 2020, making it a pivotal resource for researchers, clinicians, and students alike. The journal boasts an impressive Q1 ranking in both Orthopedics and Sports Medicine and Surgery categories, affirming its impact and relevance in an increasingly competitive academic landscape. Furthermore, it ranks #81 out of 551 in the discipline of Medicine Surgery and #66 out of 321 in Orthopedics and Sports Medicine, reflecting its high standards of publication and contribution to the field. Located in the heart of the United Kingdom, Bone & Joint Open aims to facilitate the exchange of innovative research and critical advancements, ensuring that all stakeholders have access to essential findings that drive the evolution of surgical practices and orthopedic care.

Annals of Joint, published by the renowned AME Publishing Company in China, is a pivotal open-access journal dedicated to advancing the fields of Orthopedics and Sports Medicine. With an ISSN of 2415-6809 and a commendable ranking as Q3 in its category for 2023, the journal seeks to engage a diverse audience of researchers, healthcare professionals, and students through its comprehensive coverage of innovative research, clinical practices, and emerging trends within the field. Spanning the converged years from 2019 to 2024, the journal aims to foster knowledge dissemination and collaboration amongst scholars and practitioners alike while maintaining a focus on the practical applications of orthopedic and sports medicine research. Published in Hong Kong, the journal represents a crucial platform for sharing ideas and advancing scholarly discourse, as it addresses the ever-evolving challenges in orthopedics.

Arthroplasty Today is a distinguished journal published by Elsevier that has been at the forefront of orthopedic research since its launch in 2015. With a commitment to open access, the journal provides a platform for disseminating high-quality research in both the Orthopedics and Sports Medicine fields and Surgery, holding respectable positions in Scopus rankings with an impressive Q1 and Q2 quartile status. The journal aims to foster collaboration and innovation among researchers, healthcare professionals, and students by publishing cutting-edge studies, clinical outcomes, and advancements in arthroplasty techniques. Operating out of the United States, Arthroplasty Today not only enhances visibility for its contributors but also enriches the global discourse on orthopedic procedures, catering to a diverse audience eager to stay informed of the latest findings and methodologies. Access to this wealth of information is unrestricted, ensuring that relevant knowledge is available to all stakeholders in the medical community.

The Revista Espanola de Quimioterapia, published by the SOCIEDAD ESPANOLA QUIMIOTERAPIA, is a pivotal open-access journal that has been advancing the field of clinical microbiology and pharmacology since its inception in 1989. With an E-ISSN of 1988-9518, this journal caters to a diverse audience of researchers, healthcare professionals, and students, providing them with critical insights into the latest developments in medicinal chemistry and therapeutic strategies. Located in Madrid, Spain, the journal reflects the rigorous academic standards of its associated institutions, contributing significantly to the translation of research into clinical practice. Achieving a Q3 ranking in the fields of Medicine, Microbiology, and Pharmacology in 2023 attests to its growing influence and relevance in the scientific community, making it a vital resource for those engaged in the quest for innovative solutions to pressing healthcare challenges. The journal prides itself on its commitment to maintaining an open-access model since 2018, ensuring that vital research is freely accessible to foster greater knowledge sharing and collaboration within the global scientific community.